簡介 Bio
學歷 Education
2015-06 亞洲大學 生物資訊學系 博士
PhD in Department of Bioinformatics, Asia University
2008-06 亞洲大學 生物資訊學系 碩士
MS in Department of Bioinformatics, Asia University
經歷 Experience
2023-Present 亞洲大學 生物資訊學系 教授
Professor, Department of Bioinformatics, Asia University, 2023
2020-2023 亞洲大學 生物資訊學系 副教授
Associate Professor, Department of Bioinformatics, Asia University, 2020-2023
2019-2020 亞洲大學 生物資訊學系 助理教授
Assistant Professor, Department of Bioinformatics, Asia University, 2018-2020
2008-2015 美國加州大學爾灣分校 交換學者
Exchange Visitor Scholar at the University of California, Irvine
教授
生物資訊與醫學工程學系
產學長
亞洲大學 產學營運處
副永續長
亞洲大學 永續發展辦公室
王昭能博士分別於2008年及2014年取得亞洲大學碩士與博士學位。他在2011年至2014年期間擔任美國加州大學爾灣分校電機工程與資訊科學系的交換學者。目前，他在亞洲大學生物資訊與醫學工程學系擔任教授。王博士致力於研究人工智慧的基礎理論，以促進科學發現並推動醫療個人化診斷與治療的發展。同時，他也擔任亞洲大學產學合作處處長及精準健康研究中心執行長。 作為一位生物醫學數據科學家，他的研究已產生實質影響力，受到政府、學術界和產業研究人員的關注，並為實務工作者提供了新的工具。他在多個領域擁有豐富的研究經驗，包括計算生物學、生物醫學資訊學、知識圖譜，以及數據科學在生物醫學上的應用。他已發表超過70篇學術論文，其中多篇發表於《自然通訊》等重要期刊，並擁有多項人工智慧在醫療保健領域的專利。 王博士在智慧醫療產學合作方面擁有豐富經驗，曾與亞馬遜雲端服務(AWS)、台達電子、趨勢科技、英業達、百特及聯電等公司合作開發智慧健康產業應用。目前，他擔任台灣藥品審查中心及水利署的顧問。他曾受邀在2020年NVIDIA GTC會議中分享人工智慧和GPU在精準醫療上的未來影響。
Dr. Charles C.N. Wang earned his Master's and Ph.D. degrees from Asia University in 2008 and 2014, respectively. He was an exchange scholar in the Department of Electrical Engineering and Computer Science at UC Irvine from 2011 to 2014. Currently, he holds the position of Professor in the Department of Bioinformatics and Medical Engineering at Asia University. Dr Wang investigates foundations of AI to enhance scientific discovery and facilitate individualized diagnosis and treatment in medicine. Concurrently he serves as the Director of Industry-Academia Collaboration at Asia University and the Executive Director of the Precision Health Research Center. As a biomedical data scientist, his research has had a tangible impact, which has garnered the interest of government, academic, and industry researchers and has put new tools in the hands of practitioners. He possesses extensive research experience in various fields, including computational biology, biomedical informatics, knowledge graphs, and the application of data science in biomedicine. He has published over 70 academic papers, resulting in several high-impact publications in prestigious journals like Nature Communications, and holds multiple patents for artificial intelligence applications in healthcare. Dr. Wang has substantial experience in industry-academic collaboration in smart healthcare, having collaborated with companies such as AWS, Delta Electronics, Trend Micro, Inventec, Baxter, and UMC in the development of intelligent health industry applications. Currently, he serves as a consultant for the Center for Drug Evaluation and the Water Resources Agency of Taiwan. He was invited to the 2020 NVIDIA GTC conference to share the future impact of artificial intelligence and GPU on precision healthcare.